ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone and Men's Health Articles
International expert consensus on testosterone safety
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="Nelson Vergel" data-source="post: 43315" data-attributes="member: 3"><table class='post-table ' style='width: 100%'><tr><td ><p>To address widespread concerns regarding the medical condition of testosterone (T) deficiency (TD) (male hypogonadism) and its treatment with T therapy, an international expert consensus conference was convened in Prague, Czech Republic, on October 1, 2015.<br /> <br /> <br /> Experts included a broad range of medical specialties including urology, endocrinology, diabetology, internal medicine, and basic science research. A representative from the European Medicines Agency participated in a nonvoting capacity.<br /> <br /> <br /> Nine resolutions were debated, with unanimous approval:<br /> (1) TD is a well-established, clinically significant medical condition that negatively affects male sexuality, reproduction, general health, and quality of life;<br /> (2) symptoms and signs of TD occur as a result of low levels of T and may benefit from treatment regardless of whether there is an identified underlying etiology;<br /> (3) TD is a global public health concern;<br /> (4) T therapy for men with TD is effective, rational, and evidence based;<br /> <strong>(5) THERE IS NO T CONCENTRATION THRESHOLD THAT RELIABLY DISTINGUISHES THOSE WHO WILL RESPOND TO TREATMENT FROM THOSE WHO WILL NOT;</strong><br /> <strong>(6) THERE IS NO SCIENTIFIC BASIS FOR ANY AGE-SPECIFIC RECOMMENDATIONS AGAINST THE USE OF T THERAPY IN MEN;</strong><br /> <strong>(7) THE EVIDENCE DOES NOT SUPPORT INCREASED RISKS OF CARDIOVASCULAR EVENTS WITH T THERAPY;</strong><br /> <strong>(8) THE EVIDENCE DOES NOT SUPPORT INCREASED RISK OF PROSTATE CANCER WITH T THERAPY; AND</strong><br /> (9) the evidence supports a major research initiative to explore possible benefits of T therapy for cardiometabolic disease, including diabetes.<br /> <br /> <br /> These resolutions may be considered points of agreement by a broad range of experts based on the best available scientific evidence.<br /> <br /> <br /> <strong>Morgentaler A, Zitzmann M, Traish AM, et al. Fundamental Concepts Regarding Testosterone Deficiency and Treatment: International Expert Consensus Resolutions. Mayo Clin Proc. <a href="http://www.ncbi.nlm.nih.gov/pubmed/27313122" target="_blank">http://www.ncbi.nlm.nih.gov/pubmed/27313122</a> </strong><br /></p></td></tr></table></blockquote><p></p>
[QUOTE="Nelson Vergel, post: 43315, member: 3"] [TABLE] [TR] [TD]To address widespread concerns regarding the medical condition of testosterone (T) deficiency (TD) (male hypogonadism) and its treatment with T therapy, an international expert consensus conference was convened in Prague, Czech Republic, on October 1, 2015. Experts included a broad range of medical specialties including urology, endocrinology, diabetology, internal medicine, and basic science research. A representative from the European Medicines Agency participated in a nonvoting capacity. Nine resolutions were debated, with unanimous approval: (1) TD is a well-established, clinically significant medical condition that negatively affects male sexuality, reproduction, general health, and quality of life; (2) symptoms and signs of TD occur as a result of low levels of T and may benefit from treatment regardless of whether there is an identified underlying etiology; (3) TD is a global public health concern; (4) T therapy for men with TD is effective, rational, and evidence based; [B](5) THERE IS NO T CONCENTRATION THRESHOLD THAT RELIABLY DISTINGUISHES THOSE WHO WILL RESPOND TO TREATMENT FROM THOSE WHO WILL NOT;[/B] [B](6) THERE IS NO SCIENTIFIC BASIS FOR ANY AGE-SPECIFIC RECOMMENDATIONS AGAINST THE USE OF T THERAPY IN MEN;[/B] [B](7) THE EVIDENCE DOES NOT SUPPORT INCREASED RISKS OF CARDIOVASCULAR EVENTS WITH T THERAPY;[/B] [B](8) THE EVIDENCE DOES NOT SUPPORT INCREASED RISK OF PROSTATE CANCER WITH T THERAPY; AND[/B] (9) the evidence supports a major research initiative to explore possible benefits of T therapy for cardiometabolic disease, including diabetes. These resolutions may be considered points of agreement by a broad range of experts based on the best available scientific evidence. [B]Morgentaler A, Zitzmann M, Traish AM, et al. Fundamental Concepts Regarding Testosterone Deficiency and Treatment: International Expert Consensus Resolutions. Mayo Clin Proc. [URL]http://www.ncbi.nlm.nih.gov/pubmed/27313122[/URL] [/B] [/TD] [/TR] [/TABLE] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
X (Twitter)
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone and Men's Health Articles
International expert consensus on testosterone safety
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top